InvestSMART

nanollose Limited (ASX: NC6) - Announcements

- Current share price for NC6 : $0.077

ASX company news and announcements for nanollose Limited (NC6) are delayed by 20 minutes from the time of their release between 7.30am and 7.30pm EDT and are in PDF format. All nanollose Limited (NC6) ASX announcements deemed to be price sensitive will be highlighted with . If you are looking for ASX announcements for companies other than nanollose Limited (NC6), please use our Company Announcements tool to search across all ASX-listed companies.

Latest company announcements for nanollose Limited (NC6)

Search all Announcements
Market Cap ($m) Headline Release
date/time+		 Price at
release+		 Current
price+		 Gain/Loss View
$32 Becoming a substantial holder 3 Mar 2025 8:23AM $0.020 $0.077 risen by 285%
$32 Update - Notification regarding unquoted securities - NC6 28 Feb 2025 12:49PM $0.021 $0.077 risen by 266.67%
$32 Update - Application for quotation of securities - NC6 27 Feb 2025 11:24AM $0.019 $0.077 risen by 305.26%
$32 Notification regarding unquoted securities - NC6 27 Feb 2025 9:48AM $0.020 $0.077 risen by 285%
$32 Application for quotation of securities - NC6 27 Feb 2025 9:46AM $0.020 $0.077 risen by 285%
$32 Non-Renounceable Rights Issue Offer Completes 25 Feb 2025 9:27AM $0.017 $0.077 risen by 352.94%
$32 Half Yearly Report and Accounts 20 Feb 2025 7:46PM $0.018 $0.077 risen by 327.78%
$32 Results of Meeting 20 Feb 2025 4:05PM $0.018 $0.077 risen by 327.78%
$32 Quarterly Activities/Appendix 4C Cash Flow Report 31 Jan 2025 8:59AM $0.016 $0.077 risen by 381.25%
$32 Non-Renounceable Rights Issue - Notice to Shareholders 22 Jan 2025 7:35PM $0.017 $0.077 risen by 352.94%
$32 Update - Proposed issue of securities - NC6 22 Jan 2025 2:22PM $0.017 $0.077 risen by 352.94%
$32 Notice of General Meeting/Proxy Form 21 Jan 2025 1:07PM $0.017 $0.077 risen by 352.94%
$32 Application for quotation of securities - NC6 14 Jan 2025 5:40PM $0.019 $0.077 risen by 305.26%
$32 Change of Director's Interest Notice 14 Jan 2025 1:39PM $0.019 $0.077 risen by 305.26%
$32 Update - Proposed issue of securities - NC6 14 Jan 2025 9:08AM $0.019 $0.077 risen by 305.26%
$32 Entitlement Issue Prospectus 14 Jan 2025 8:15AM $0.019 $0.077 risen by 305.26%
$32 Notification of cessation of securities - NC6 13 Jan 2025 8:25PM $0.019 $0.077 risen by 305.26%
$32 Ceasing to be a substantial holder 3 Jan 2025 8:21AM $0.019 $0.077 risen by 305.26%
$32 Becoming a substantial holder 24 Dec 2024 11:51AM $0.019 $0.077 risen by 305.26%
$32 Application for quotation of securities - NC6 23 Dec 2024 10:20AM $0.019 $0.077 risen by 305.26%
$32 Becoming a substantial holder 20 Dec 2024 7:56PM $0.019 $0.077 risen by 305.26%
$32 Change of Director's Interest Notice 13 Dec 2024 7:28PM $0.019 $0.077 risen by 305.26%
$32 Notification of cessation of securities - NC6 13 Dec 2024 7:19PM $0.019 $0.077 risen by 305.26%
$32 Proposed issue of securities - NC6 13 Dec 2024 9:57AM $0.030 $0.077 risen by 156.67%
$32 Strategic $2.1M Capital Raising 13 Dec 2024 9:57AM $0.030 $0.077 risen by 156.67%

101 - 125 of 409 results

Page 5 of 17

  • + Company announcements and prices are delayed by least 20 minutes. Prices are indicative only.

DISCLOSURE: InvestSMART Group Limited employees may have an interest in the securities and managed funds displayed via this service. Please refer to our Financial Services Guide for more information.

Data shown on this website is sourced by Morningstar
© Morningstar. All rights reserved. Neither any Morningstar company nor any of their content providers guarantee the data or content contained herein to be accurate, complete or timely nor will they have any liability for its use or distribution. Any general advice has been prepared by Morningstar Australasia Pty Ltd (ABN: 95 090 665 544, AFSL: 240892) and/or Morningstar Research Limited, subsidiaries of Morningstar, Inc, without reference to your objectives, financial situation or needs. You should consider the advice in light of these matters and, if applicable, the relevant Product Disclosure Statement (in respect of Australian products) or Investment Statement (in respect of New Zealand products) before making any decision to invest. No Morningstar-affiliated company or any of their employees is providing you with personalised financial advice. To obtain advice tailored to your particular circumstances, please contact a professional financial adviser. Some material is copyright and published under licence from ASX Operations Pty Limited ACN 004 523 782 ("ASXO"). Data and content is provided for personal use only.